Search
Theravance Biopharma Inc
TBPHAdd to Watchlist
16.860USD
+0.010+0.06%
Close 07-31 16:00（ET）Quotes delayed by 15 min
873.82MMarket Cap
7.39P/E TTM
Theravance Biopharma Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Theravance Biopharma Inc is 7.35, ranking 109 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 7.39, which is 716.69% below the recent high of 60.35 and 346.83% above the recent low of -18.24.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.